Addex Therapeutics Ltd Cash Flow-to-Debt Ratio
Addex Therapeutics Ltd cash flow-to-debt ratio. Addex Therapeutics Ltd (ADXN) has a Cash Flow-to-Debt Ratio of -0.52x as of March 2026, meaning its operating cash flow of $-765.84K could theoretically repay -1% of its total liabilities ($1.47 Million) in one year. Check earnings quality score of Addex Therapeutics Ltd to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Addex Therapeutics Ltd (2006–2025)
Cash flow-to-debt ratio of Addex Therapeutics Ltd from 2006 to 2025. Historical debt coverage capacity for Addex Therapeutics Ltd across 20 annual periods. Check Addex Therapeutics Ltd (ADXN) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Addex Therapeutics Ltd Cash Flow-to-Debt Ratio by Year (2006–2025)
Addex Therapeutics Ltd cash flow-to-debt ratio by year from 2006 to 2025. Year-by-year debt coverage analysis for Addex Therapeutics Ltd. For the full cash flow conversion analysis, see Addex Therapeutics Ltd operating cash flow efficiency.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.30x | $-2.08 Million | $1.60 Million | ▲ +75.8% |
| 2024 | -5.37x | $-5.37 Million | $1.00 Million | ▼ -134.8% |
| 2023 | -2.29x | $-7.99 Million | $3.50 Million | ▲ +53.1% |
| 2022 | -4.88x | $-16.44 Million | $3.37 Million | ▼ -86.1% |
| 2021 | -2.62x | $-14.71 Million | $5.61 Million | ▼ -19.9% |
| 2020 | -2.19x | $-12.18 Million | $5.57 Million | ▼ -73.0% |
| 2019 | -1.26x | $-9.48 Million | $7.50 Million | ▼ -314.4% |
| 2018 | 0.59x | $1.75 Million | $2.97 Million | ▲ +147.5% |
| 2017 | -1.24x | $-2.13 Million | $1.72 Million | ▲ +32.6% |
| 2016 | -1.84x | $-2.69 Million | $1.46 Million | ▲ +14.2% |
| 2015 | -2.14x | $-2.63 Million | $1.23 Million | ▼ -97.1% |
| 2014 | -1.09x | $-1.80 Million | $1.65 Million | ▲ +80.3% |
| 2013 | -5.53x | $-15.78 Million | $2.85 Million | ▼ -2.2% |
| 2012 | -5.41x | $-29.45 Million | $5.44 Million | ▼ -99.3% |
| 2011 | -2.71x | $-26.55 Million | $9.78 Million | ▲ +14.5% |
| 2010 | -3.18x | $-31.34 Million | $9.87 Million | ▲ +11.5% |
| 2009 | -3.59x | $-39.38 Million | $10.97 Million | ▼ -169.0% |
| 2008 | -1.33x | $-17.79 Million | $13.34 Million | ▲ +62.5% |
| 2007 | -3.56x | $-33.00 Million | $9.27 Million | ▲ +25.8% |
| 2006 | -4.80x | $-19.56 Million | $4.07 Million | — |